Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)
Hong Kong · Delayed Price · Currency is HKD 1.160
+0.020 (1.75%)
Apr 2, 2026, 2:27 PM HKT
HKG:2348 Revenue
In the year 2025, Dawnrays Pharmaceutical (Holdings) had annual revenue of 1.23B CNY with 16.09% growth. Dawnrays Pharmaceutical (Holdings) had revenue of 600.44M in the half year ending December 31, 2025, with 19.80% growth.
Revenue
1.23B CNY
Revenue Growth
+16.09%
P/S Ratio
1.27
Revenue / Employee
1.10M CNY
Employees
1,116
Market Cap
1.74B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.23B | 170.56M | 16.09% |
| Dec 31, 2024 | 1.06B | -90.84M | -7.89% |
| Dec 31, 2023 | 1.15B | -126.54M | -9.90% |
| Dec 31, 2022 | 1.28B | 112.53M | 9.66% |
| Dec 31, 2021 | 1.17B | 140.89M | 13.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chia Tai Enterprises International | 4.17B |
| Essex Bio-Technology | 1.81B |
| Jacobson Pharma Corporation | 1.53B |
| Lee's Pharmaceutical Holdings | 1.44B |
| Golden Throat Holdings Group Company | 1.05B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.02B |
| JBM (Healthcare) | 812.98M |
| Hua Medicine (Shanghai) | 548.54M |